Molecular Analyzer Binx io® CLIA Waived Sample Dependent

Features

• Binx io is the first ever
• FDA-cleared
• molecular point-of-care platform that enables clinicians to test and treat women and men for the most common STIs
• chlamydia and gonorrhea
• in a single office visit Binx io is a small
• desktop instrument that processes a single-use
• assay-specific cartridge with no sample preparation necessary The binx io has been cleared by the FDA for use in point-of-care and clinical laboratory settings for the rapid and accurate detection of chlamydia and gonorrhea in vaginal swab and first catch urine samples collected by either a clinician or patient 3.30.21 CLIA waived for binx health io Instrument (use with female vaginal swabs and male urine) for both Chlamydia and Neisseria gonorrhoeae